⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Calyx Chemicals and Pharmaceuticals Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Calyx Chemicals and Pharmaceuticals Limited is an established Indian pharmaceutical company founded in 1979. It specializes in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, with a strong focus on therapeutic areas such as anti-tuberculosis, anti-malarial, and macrolide drugs.
The company operates state-of-the-art manufacturing facilities in Maharashtra, India, which have received approvals from international regulatory bodies including the EDQM, WHO-Geneva, and WHO-GMP. Calyx also provides custom synthesis and contract research and manufacturing services (CRAMS) to global markets, maintaining a reputation for compliance and quality in regulated pharmaceutical sectors.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$20M-$50M
Founded:1979
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:Symbiotec, Neuland Laboratories, Hikal
LEADERSHIP
Key Executives:
Smitesh Chandravadan Shah - Chairman & Managing Director
Khandu Vishnu Varal - Director
Board Members:Sanket Khandu Varal, Gulab Bajirao Parwe, Vasant Ghisulal Jain, Sunita Ajay Nair, Ritik Vasant Jain
LINKS
Website:calyxindia.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Calyx Chemicals and Pharmaceuticals Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.